FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Lisinopril Tablets USP

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot # Q000255, Exp 01/2022
Where it was soldProduct was distributed Nationwide in the United States.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byLupin Limited Pithampur (M.P.) 454 775, India foreign manufacturer
Distributed by / forLupin Pharmaceuticals, Inc. Baltimore MD 21202
NDC68180-0981-03
Show the full FDA record
Full product labelLisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03
Recalling firmLupin Pharmaceuticals Inc.
DistributionProduct was distributed Nationwide in the United States.
Quantity11,808 bottles
Recall initiated2020-04-20
Report date2020-04-29
Recall completed2021-06-07
Recall numberD-1250-2020
ClassificationClass II
FDA statusTerminated
Origin on fileBaltimore MD United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.